Biodefense Market Size, Share, Growth, Sales, Trade, Shipment, Export Value And Volume With Sales And Pricing Forecast By 2029

Global Biodefense Market: Synopsis

The growth of the global biodefense market can be evaluated by analysing the existing threats to the masses from various infectious diseases. Biodefense is an umbrella term used for several types of treatments and vaccinations administered to protect the masses against biological threats or diseases. Biodefense has become a commercial industry as new threats dominate the healthcare industry. There are several narratives around the use of bioterrorism by anarchy-prone foes across regional borders. Therefore, biodefense is also considered to be a means of countering bioterrorism. However, medical practitioners consider biodefense as a tool to protect the masses against severe infections, plagues, and outbreaks. In either case, the use of biodefense technologies is slated to increase over the next decade.

This is a customized review on the global biodefense market, written to sheds value on of the key trends shaping market growth and maturity. Biodefense has become a widely-used term that is expected to gather more popularity in the times to follow. This review provides draws various scenarios that can become the premise of growth across the global healthcare industry. Use of biodefense is also amongst the many scenarios that could shape the future of the healthcare sector. This review also provides an overview of market growth in the context of the COVID-19 pandemic.

Global Biodefense Market: Notable Developments

The growth of the biodefense market relies on the extent to which biosecurity is prioritized across the healthcare industry.

• Several labs across a multitude of countries have begun various phases of their trials for the COVID-19 vaccine. Many of these labs consider the vaccine as a biodefense tool that could protect large populations against the virus. Thermo Fisher is amongst the many companies that are leading the cause for developing anti-COVID-19 antibodies. This is an important step by the company towards making its mark in the fight against the pandemic, and to become a strong proponent of biodefense.

• The importance of bio-surveillance has become a key driver of demand within the global biodefense market. Several market players in the biodefense market have utilized the importance of rural biodefense for pandemic management and preparedness as a means to drive sales. The next decade would be a phase of lucrative opportunities for the market players, depending on the impact of the pandemic on global health.

Key Players:

• Emergent Biosolutions Inc.
• SIGA Technologies.
• Dynavax Technologies Corporation.
• Ichor Medical Systems.
• Elusys Therapeutics Inc.

Global Biodefense Market: Growth Drivers

• Use of Military and Defense

The domain of biodefense has become a core component of the military industry at large. Bioterrorism attacks are targeted on the defense personnel of nation through inhibition or contamination of water and food supplies. Therefore, the total worth of the biodefense market is growing alongside advancements in military and defense technologies. Medical research institutes affiliated to the army and military of regions are making ceaseless efforts to develop biodefense mechanisms. This is also an important consideration from the point of sales across the market.

• Identification of Bioweapons

The use of biodefense is proven across several regional territories, and is believed to be a means of gaining political leverage. However, it is unclear whether bioterrorism is associated with infections and diseases alone. Despite the skewed analogies and narratives around bioterrorism, several analysts believe biological weapons come in the form of animal diseases. This is an important factor that is propelling sales across the biodefense market.

Global Biodefense Market: Regional Segments

• North America
• Europe
• Asia Pacific
• South America
• The Middle East and Africa